TTY

TTY is committed to building itself as a biotech pharmaceutical company advanced in drug development and international marketing. On one hand, TTY is continuously improving its ability to gear to international developments in areas such as international technical documentation formats (CMC, CTD), execution of international clinical trials, and manufacturing process which matches EMEA and FDA specifications. On the other hand, TTY continues to carefully select the most suitable collaborative partners for new drug development around the world and various target markets. Other than continuing operation in the core channels (medical centers, regional hospitals, district hospitals with development potentials) in Taiwan, TTY will enter the international market through developing high barrier and concept-proved new drugs and biologics with innovative formulations. Presently, TTY has been successful in introducing its own R&D products to regions including EU, Asian Pacific, Middle East..

Also known as: TTY Biopharm Co., Ltd., TTY Group, TTYBiopharmCompanyLimited

Primary location: Taipei Taiwan R.o.c.